课题基金 / 基金详情

RobotReviewer: development and evaluation of a machine learning tool to speed up evidence synthesis in cardiovascular diseases

RobotReviewer: development and evaluation of a machine learning tool to speed up evidence synthesis in cardiovascular diseases
RobotReviewer:开发和评估机器学习工具,以加速心血管疾病的证据合成
批准号:
MR/N015185/1
负责人:
Iain Marshall
金额:
$42.05万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I am an academic GP, whose research background is in systematic reviewing. I previously worked as a Clinical Editor at the systematic reviews journal BMJ Clinical Evidence, and am about to submit my PhD thesis which looks at how best to communicate with patients about medical research about cardiovascular diseases (heart attack, stroke, and diseases of the large blood vessels).I am applying for the Skills Development fellowship in Informatics due to a strong interest and aptitude in computer programming and statistics. This fellowship aims to further develop a computer system called RobotReviewer, which I have developed in collaboration with researchers in the US and the Netherlands.RobotReviewer supports researchers producing a type research called a systematic review. Systematic reviews are articles which aim to summarise all relevant research on a particular topic. Systematic reviews are particularly helpful to clinicians, since it is not practical to keep on top of the vast amount of research published. Systematic reviews give a balanced view on the research, giving prominence to large and high quality studies, and examining whether research is at risk of bias.Producing systematic reviews is laborious, taking a team 2 years on average. A large proportion of existing reviews are out of date, and reviews do not yet exist for many urgently needed topics. This is particularly the case in cardiovascular diseases, where reviews are typically out of date within 2 years. Technologies to speed up the production of systematic reviews are therefore urgently needed.Data extraction is a key (and time-consuming) task in producing a systematic reviews, and the one on which this proposal focuses. Here, human reviewers start with all the research they intend to summarise (typically a large pile of paper documents), and identify detailed information including on how the trial was done and statistical results. These data are then entered into a standard template designed for the review. This task is done in duplicate to ensure high accuracy.RobotReviewer works by taking in a large library of existing systematic reviews, together with articles describing clinical trials (in PDF format). RobotReviewer is able to take this data, and learn how to identify the key pieces of information in a clinical trial report which are needed to produce a systematic review. So far, RobotReviewer is able to help with the task of assessing whether clinical trials are at risk of bias. We compared the accuracy of RobotReviewer on this task against human researchers, and found that RobotReviewer was equally accurate at finding the text which discussed bias. Overall RobotReviewer was 70% accurate at judging whether a trial was biased, compared with humans who were 77% accurate.This fellowship aims to develop the technology further, so that RobotReview is able to extract many other important pieces of information, including descriptions of the participants in clinical trials, the types of treatments they used, and data on what the benefits and harms of the treatments were.After the technology has been developed, it will be tested, comparing its accuracy against the accuracy of human researchers doing the same task.In order to get the technology as widely used as possible, the computer software will be released freely. Additionally, I am working with key people in the Cochrane Collaboration (an international charity who are the world's leading producer of systematic reviews), who are interested in piloting the use of the automation technology in their work.As part of the fellowship I intend to undertake specialist training in statistics and computer science required for the project. Additionally, I will continue to collaborate with computer scientists in the US and the Netherlands on the project to develop my skills further.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.18653/v1/d18-1497
发表时间: 2018-10
期刊: Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing
影响因子: --
作者: [Jain S, Banner E, van de Meent JW, Marshall IJ, Wallace BC]
通讯作者: Wallace BC
State of the evidence: a survey of global disparities in clinical trials
证据状况:临床试验全球差异的调查
DOI: 10.1101/2020.10.08.20209353
发表时间: 2020
期刊:
影响因子: --
作者: [Marshall I]
通讯作者: Marshall I
MOESM1 of Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
血液嗜酸性粒细胞计数的 MOESM1,是事后 RCT 和观察性研究中吸入皮质类固醇在预防 COPD 恶化方面有效性的标志物:系统评价和荟萃分析
DOI: 10.6084/m9.figshare.11508249
发表时间: 2020
期刊:
影响因子: --
作者: [Harries T]
通讯作者: Harries T
DOI: 10.1371/journal.pone.0175980
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者: [Jain V, Marshall IJ, Crichton SL, McKevitt C, Rudd AG, Wolfe CDA]
通讯作者: Wolfe CDA
国内基金
海外基金
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
  • 批准号:
    82371721
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王星云
  • 依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
  • 批准号:
    82371668
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    乔云波
  • 依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
  • 批准号:
    82371276
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    严佳
  • 依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位: